These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16164734)

  • 1. Therapy-resistant leg ulcer caused by multiple myeloma.
    Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel agents in first-line therapy for myeloma.
    Jagannath S
    Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy resistant leg ulcer caused by multiple myeloma].
    Bagó A; Schweitzer K; Kis M; Fúrész J; Vajda A; Baló-Banga JM
    Orv Hetil; 2003 Sep; 144(37):1829-32. PubMed ID: 14596021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple complications in multiple myeloma.
    Basi S; Schulman G; Fogo AB
    Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical effectiveness of filgrastim in beta-thalassaemia leg ulcer.
    Stavrianeas N; Xifteri A; Kavatha D; Vrettou H
    Dermatology; 2005; 211(2):173;author reply 173. PubMed ID: 16088173
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 7. Scar leishmaniasis.
    Arfan-ul-Bari ; Simeen-ber-Rahman
    J Coll Physicians Surg Pak; 2006 Apr; 16(4):294-5. PubMed ID: 16624197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.
    Wada N; Fujimoto N; Komatsu T; Tajima S; Ishibashi A
    Eur J Dermatol; 2002; 12(6):607-8. PubMed ID: 12459542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cases of plasma cell leukemia with atypical immunophenotype.
    Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
    Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
    [No Abstract]   [Full Text] [Related]  

  • 10. Myeloma bone disease: pathogenesis and treatment.
    Roodman GD;
    Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
    Bergner R; Hoffmann M; Uppenkamp M
    Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-secretory multiple myeloma with hypercalcemic acute renal failure.
    Prakash MS; Baliga KV; Singh AP; Mishra DK
    J Assoc Physicians India; 2002 Oct; 50():1330-1. PubMed ID: 12568228
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin.
    Al-Niaimi F; Lyon C
    J Am Acad Dermatol; 2011 Jul; 65(1):227-9. PubMed ID: 21679830
    [No Abstract]   [Full Text] [Related]  

  • 14. Bulbar palsy in multiple myeloma.
    Chim CS; Ooi GC
    Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines on the diagnosis and management of multiple myeloma 2005.
    Smith A; Wisloff F; Samson D; ; ;
    Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe leg ulcers in a multiple myeloma patient with cryoglobulinemic vasculitis.
    Jiménez-Encarnación E; García-Pallas MV; Vilá LM
    P R Health Sci J; 2012 Jun; 31(2):71. PubMed ID: 22783699
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers.
    Shelling ML; Federman DG; Kirsner RS
    Arch Dermatol; 2010 Sep; 146(9):1026-9. PubMed ID: 20855705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meningitis caused by Listeria monocytogenes in the patient with multiple myeloma].
    Pokrovskaia OS; Mendeleeva LP; Gribanova EO; Ustinova EN; Kliasova GA; Sharikova OA; Galstian GM; Iatskov KV; Varlamova EIu; Kaplanskaia IB
    Ter Arkh; 2003; 75(7):76-8. PubMed ID: 12934487
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose tissue plasminogen activator for calciphylaxis.
    Sewell LD; Weenig RH; Davis MD; McEvoy MT; Pittelkow MR
    Arch Dermatol; 2004 Sep; 140(9):1045-8. PubMed ID: 15381542
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous involvement in multiple myeloma and bortezomib.
    Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
    Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.